From: Screening strategies for adults with type 2 diabetes mellitus: a systematic review protocol
Diabetes | |
āFasting plasma glucose | ā„ 7.0āmmol/L (126āmg/dl) OR |
ā2-h plasma glucose* | ā„ 11.1āmmol/L (200āmg/dl) OR |
āHbA1c | ā„ 6.5% |
Impaired glucose tolerance (IGT) | |
āFasting plasma glucose | < 7.0āmmol/L (126āmg/dl) AND |
ā2-h plasma glucose* | ā„ 7.8 and < 11.1āmmol/L (140āmg/dl and 200āmg/dl) |
Impaired fasting glucose (IFG) | |
āFasting plasma glucose | 6.1 to 6.9āmmol/L (110āmg/dl to 125āmg/dl) AND (if measured) |
ā2-h plasma glucose* | < 7.8āmmol/L (140āmg/dl) |